$ABCM News
Last published 2y ago
- 2y agoABCMMetabolism Assays Market Size Projected to Reach USD 3.1 Billion by 2034, Growing Steadily at 6.7% CAGR | Report by Transparency Market Research, IncGlobeNewswireWilmington, Delaware, United States, Transparency Market Research, Inc., Aug. 28, 2024 (GLOBE NEWSWIRE) -- As per the report published by Transparency Market Research, the global metabolism assays market (대사 분석 시장) was
- 2y agoDHRABCMDanaher Completes Acquisition of AbcamPR NewswireDanaher Corporation (NYSE:DHR) ("Danaher") announced today it has completed its acquisition of Abcam plc (NASDAQ:ABCM) ("Abcam"). The acquisition of...
- 2y agoABCMDHRAcquisition of Abcam by Danaher Approved by the High Court of Justice of England and WalesBusiness WireAbcam plc (NASDAQ:ABCM) (‘Abcam', the ‘Group' or the ‘Company'), a global leader in the supply of life science research tools, entered into a definitive agreement on August 26, 2023 relating to its proposed acquisition
- 2y agoABCMDHRAbcam Acquisition by Danaher Has Received All Identified Clearances; Transaction Expected to Close on December 6, 2023Business WireAbcam plc (NASDAQ:ABCM) (‘Abcam', the ‘Group' or the ‘Company'), a global leader in the supply of life science research tools, which entered into a definitive agreement on August 26, 2023 relating to its proposed
- 3y agoABCMDHRShareholders of Abcam Approve Proposed Acquisition by DanaherBusiness WireAbcam plc (NASDAQ:ABCM) (‘Abcam', the ‘Group' or the ‘Company'), a global leader in the supply of life science research tools, which entered into a definitive agreement on August 26, 2023 relating to its proposed
- 3y agoABCMDHRStatement from Dr. Jonathan Milner on the suspension of the "Vote AGAINST" campaignGlobeNewswireStatement from Dr. Jonathan Milner on the suspension of the "Vote AGAINST" campaign CAMBRIDGE, England, 1 November 2023 - Jonathan Milner, the founder and one of the largest investors in Abcam plc ("Abcam" or the
- 3y agoABCMLeading Independent Proxy Advisor Glass Lewis Joins ISS in Recommending Shareholders Vote "FOR" Danaher Corporation's Proposed Acquisition of AbcamBusiness WireBoth Leading Proxy Advisors ISS and Glass Lewis Acknowledge the Thorough Process Undertaken by the Abcam Board in Reaching an Agreement that Provides a Compelling Premium and Certainty of Value to Abcam
- 3y agoABCMDHRJonathan Milner Issues Statement Responding to the Glass Lewis ReportGlobeNewswireJonathan Milner Issues Statement Responding to the Glass Lewis Report Welcomes the Glass Lewis report's observations on the disproportionate rewards for Abcam's Executive Directors and on the identified issues with
- 3y agoABCMLeading Proxy Advisor, ISS, Recommends Shareholders Vote "FOR" Danaher Corporation's Proposed Acquisition of AbcamBusiness WireISS Acknowledges the Thorough Process Undertaken by the Abcam Board in Reaching an Agreement that Provides a Premium and Certainty of Value to Abcam Shareholders Abcam plc (NASDAQ:ABCM) (‘Abcam,' the ‘Group' or the
- 3y agoABCMDHRJonathan Milner Issues Statement Responding to ISS ReportGlobeNewswireJonathan Milner Issues Statement Responding to ISS Report Urges shareholders to disregard the ISS report and continue to Vote AGAINST the current proposed acquisition of Abcam by Danaher CAMBRIDGE, England, 16 October
- 3y agoABCMDHRJonathan Milner releases presentation to Abcam plc shareholders, outlining reasons to reject Danaher's bid and strategic vision for the CompanyGlobeNewswireJonathan Milner releases presentation to Abcam plc shareholders, outlining reasons to reject Danaher's bid and strategic vision for the Company CAMBRIDGE, England, 16 October 2023 – Dr. Jonathan Milner, the founder
- 3y agoABCMDHRIndependent Directors of Abcam Highlight Compelling Reasons for Shareholders to Support Proposed Sale to DanaherBusiness WireAbcam plc (NASDAQ:ABCM) (‘Abcam,' the ‘Group' or the ‘Company'), a global leader in the supply of life science research tools, today filed an investor presentation with the U.S. Securities and Exchange Commission
- 3y agoABCMDHRJonathan Milner issues Open Letter to shareholders of Abcam plcGlobeNewswireUrges shareholders to question the scheme circular, the unacceptable Offer price and continue to Vote AGAINST the current proposed acquisition of Abcam by Danaher Corporation Reiterates a sale at the right price, to
- 3y agoABCMDHRAbcam Files and Mails Scheme Circular Seeking Approval of Acquisition of Abcam by Danaher for $24.00 per ShareBusiness WireAbcam plc (NASDAQ:ABCM) (‘Abcam', the ‘Group' or the ‘Company'), a global leader in the supply of life science research tools, today filed and mailed a scheme circular (the 'Scheme Circular‘) in connection with the
- 3y agoABCMDHRJonathan Milner issues Open Letter to shareholders of Abcam plcGlobeNewswireJonathan Milner issues Open Letter to shareholders of Abcam plc Urges shareholders to Vote AGAINST the proposed acquisition of Abcam by Danaher Corporation CAMBRIDGE, England, 28 September 2023 – Dr. Jonathan
- 3y agoABCMAbcam plc Statement on Dr. Jonathan Milner's AnnouncementBusiness WireAbcam plc (NASDAQ:ABCM) ("Abcam" or the "Company"), notes today's announcement by Dr. Jonathan Milner. The Company considers it surprising that Dr. Milner has taken active steps to oppose the deal without reviewing the
- 3y agoABCMDHRDr. Jonathan Milner opposes Danaher's acquisition of Abcam and calls for EGM to replace BoardGlobeNewswireDr. Jonathan Milner opposes Danaher's acquisition of Abcam and calls for EGM to replace Board CAMBRIDGE, England, 14 September 2023 – Dr. Jonathan Milner, the founder and one of the largest investors in Abcam plc
- 3y agoABCMHTRPTTHRNMoore Kuehn Encourages RPT, ABCM, THRN, and HT Investors to Contact Law FirmGlobeNewswireNEW YORK, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the
- 3y agoABCMAbcam plc Interim Results for the Six-Month Period Ended 30 June 2023Business WireAbcam plc (NASDAQ:ABCM) (‘Abcam', the ‘Group' or the ‘Company'), a global leader in the supply of life science research tools, today announces its interim results for the six-month period ended 30 June 2023 (the
- 3y agoABCMDHRDanaher to acquire Abcam for $24.00 per ShareBusiness WireAbcam plc (NASDAQ:ABCM) (‘Abcam', the ‘Group' or the ‘Company'), a global leader in the supply of life science research tools, announced today that it has entered into a definitive agreement pursuant to which Danaher
- 3y agoABCMDHRDanaher to Acquire AbcamPR NewswireWASHINGTON, Aug. 28, 2023 /PRNewswire/ -- Danaher Corporation (NYSE:DHR) ("Danaher" or the "Company"), a global science and technology innovator, announced today that it has entered into a definitive
- 3y agoABCMAbcam plc: All Resolutions Withdrawn at Abcam's EGMPR NewswireCAMBRIDGE, England and WALTHAM, Mass., July 12, 2023 /PRNewswire/ -- Abcam plc ("Abcam," "Company," "Group") (NASDAQ:ABCM), a global leader in the supply of life science research tools, today held
- 3y agoABCMABCAM PLC: Trading UpdatePR NewswireCAMBRIDGE, England, July 5, 2023 /PRNewswire/ -- Abcam plc ("Abcam," "Company," "Group") (NASDAQ:ABCM), a global leader in the supply of life science research tools, today provides the following
- 3y agoABCMAbcam Confirms Dr. Jonathan Milner has Withdrawn EGM Requisition Notice and Related ResolutionsBusiness WireShareholders are encouraged not to attend or submit voting instructions or proxies related to the EGM Abcam plc ("Abcam," "Company," "Group") (NASDAQ:ABCM), a global leader in the supply of
- 3y agoABCMStarboard Issues Statement Regarding the Opportunity to Maximize Value at AbcamBusiness WireBelieves the Board of Directors is Taking the Right Step by Commencing a Review of Strategic Alternatives, Including a Potentially Value-Maximizing Sale Supports Founder Dr. Jonathan Milner's Decision to Temporarily
- 3y agoABCMAbcam plc: FY2024 GuidanceBusiness WireAbcam plc ("Abcam," "Company," "Group") (NASDAQ:ABCM), a global leader in the supply of life science research tools, today provides the following updates. Although the Company acknowledges that these financial updates
- 3y agoABCMABCZFAbcam Announces Review of Strategic AlternativesPR NewswireCAMBRIDGE, England and WALTHAM, Mass., June 23, 2023 /PRNewswire/ -- Abcam plc ("Abcam," "Company," "Group") (NASDAQ:ABCM), a global leader in the supply of life science research tools, today
- 3y agoABCMJonathan Milner issues Open Letter to shareholders of Abcam plcGlobeNewswireJonathan Milner issues Open Letter to shareholders of Abcam plc Highlights Abcam Board's track record of failing to pursue strategic M&A opportunities and lack of incentive to drive share performance Urges all ADS
- 3y agoABCMJonathan Milner issues Open Letter to shareholders of Abcam plcGlobeNewswireJonathan Milner issues Open Letter to shareholders of Abcam plc Responds to Company's assertions in its statement on 20 June 2023 Outlines Abcam's lack of focus and Milner's detailed plans to restore the Company's
- 3y agoABCMAbcam Highlights Successful Execution of Strategic Priorities to Drive Shareholder ValueBusiness WireFiles investor presentation; urges shareholders to vote AGAINST all resolutions at July 12 EGM Under CEO Alan Hirzel's leadership, Abcam has transformed as a business, created significant value for all stakeholders,
- 3y agoABCMAbcam plc files and mails Shareholder Circular calling an Extraordinary General MeetingBusiness WireHighlights progress in delivering on long-term plan and outlines attempts to engage constructively with Dr. Jonathan Milner Asks shareholders to support the Company and vote "AGAINST" all resolutions to be proposed at
- 3y agoABCMJonathan Milner issues Open Letter to shareholders of Abcam plcGlobeNewswireJonathan Milner issues Open Letter to shareholders of Abcam plc Highlights Company's loss of focus on governance, execution and cost control leading to value destruction and a share price materially below where it
- 3y agoABCMABCAM PLC: Statement on calling an Extraordinary General MeetingPR NewswireCAMBRIDGE, England and WALTHAM, Mass., May 30, 2023 /PRNewswire/ -- Abcam plc ("Abcam," "Company," "Group") (NASDAQ:ABCM), a global leader in the supply of life science research tools, notes that
- 3y agoABCMJonathan Milner calls Extraordinary General Meeting to restore focus to Abcam on governance, execution, and cost controlGlobeNewswireJonathan Milner calls Extraordinary General Meeting to restore focus to Abcam on governance, execution, and cost control Proposal to appoint Jonathan Milner Executive Chairman of the Board Proposal to remove Peter
- 3y agoABCMABCZFAbcam PLC: Statement on potential Extraordinary General MeetingPR NewswireCAMBRIDGE, England and WALTHAM, Mass., May 17, 2023 /PRNewswire/ -- Abcam plc (NASDAQ:ABCM), ("Abcam," "Company," "Group") (NASDAQ:ABCM), a global leader in the supply of life science research
- 3y agoABCMABCZFABCAM PLC Result of Annual General MeetingPR NewswireCAMBRIDGE, England and WALTHAM, Mass, May 17, 2023 /PRNewswire/ -- Abcam plc (NASDAQ:ABCM), a global leader in the supply of life science research tools, announces the voting results from the Annual General Meeting (the
- 3y agoABCMJonathan Milner Announces That He is Taking Steps to Call an Extraordinary General Meeting of Abcam ShareholdersGlobeNewswireJonathan Milner Announces That He is Taking Steps to Call an Extraordinary General Meeting of Abcam Shareholders Delivers Open Letter to Abcam shareholders Follows sustained period of operational underperformance since
- 3y agoABCMAbcam, plc Business UpdatePR NewswireCAMBRIDGE, England and WALTHAM, Mass., May 4, 2023 /PRNewswire/ -- Abcam plc ("Abcam," "Company," "Group") (NASDAQ:ABCM), a global leader in the supply of life science research tools, today
- 3y agoABCMABCAM PLC Comments on Investor EngagementPR NewswireCAMBRIDGE, England and WALTHAM, Mass., May 1, 2023 /PRNewswire/ -- Abcam plc ("Abcam," "Company," "Group") (NASDAQ:ABCM), a global leader in the supply of life science research tools, notes the
- 3y agoABCMABCZFABCAM PLC: Upcoming Abcam Investor EventsPR NewswireCAMBRIDGE, England and WALTHAM, Mass., April 17, 2023 /PRNewswire/ -- Abcam plc ("Abcam," "Company," "Group") (NASDAQ:ABCM), a global leader in the supply of life science research tools, today
- 3y agoABCMLunaphore and Abcam Announce Agreement for Primary Antibody Validation for Use on COMET™, Combining Power of Trusted Antibody Provider With Superior Multiplex CapabilitiesBusiness WireLunaphore, a Swiss life sciences company developing technology to enable spatial biology in every laboratory, and abcam (NASDAQ:ABCM), a global life science company working together with researchers to advance science
- 3y agoABCMAbcam, plc Publication of 2022 Annual Report and Accounts and Notice of Annual General MeetingPR NewswireCAMBRIDGE, England and WALTHAM, Mass., March 30, 2023 /PRNewswire/ -- Abcam plc (NASDAQ:ABCM), a global leader in the supply of life science research tools, announces that, following release on 20 March 2023 of its final
- 3y agoABCMABCAM PLC: Final results for the year ended 31 December 2022PR Newswire15% Reported Revenue Growth & 8% Constant Exchange Rate Revenue Growth: Demand for Abcam In-house Products Continues CAMBRIDGE, England and WALTHAM, Mass. , March 20, 2023 /PRNewswire/ -- Abcam plc (NASDAQ:ABCM)
- 3y agoABCMABCZFAbcam to Report Full Year Results on Monday, March 20, 2023PR NewswireCAMBRIDGE, England and WALTHAM, Mass., March 10, 2023 /PRNewswire/ -- Abcam plc (NASDAQ:ABCM) ("Abcam" or the "Company"), a global leader in the supply of life science research tools, will report its
- 3y agoABCMABCAM PLC: Trading UpdatePR NewswireCAMBRIDGE, England and WALTHAM, Mass., Jan. 30, 2023 /PRNewswire/ -- Abcam plc ("Abcam," "Company," "Group") (NASDAQ:ABCM), a global leader in the supply of life science research tools, today
- 3y agoABCMABCZFAbcam plc: Update on AIM DelistingPR NewswireCAMBRIDGE, England and WALTHAM, Mass., Dec. 12, 2022 /PRNewswire/ -- Abcam plc, (AIM: ABC) and (NASDAQ:ABCM) ("Abcam" or the "Company"), a global leader in the supply of life science research tools, today
- 4y agoABCMABCZFABCAM PLC: Result of General Meeting - Shareholders approve AIM DelistingPR NewswireCAMBRIDGE, England and WALTHAM, Mass., Nov. 11, 2022 /PRNewswire/ -- Abcam plc (AIM: ABCM) (ABC: ABCM) (NASDAQ:ABCM) ("Abcam" or the "Company"), a global leader in the supply of life science research
- 4y agoABCMNSTGNanoString and Abcam Expand Collaboration to Advance Spatial Multiomics ResearchBusiness WireInclusion of Abcam validated antibodies in CosMx curated protein panel provides the first high-plex spatial multiomic solution at single-cell and subcellular resolution Data from the CosMx human immuno-oncology 64-plex
- 4y agoABCMABCAM PLC: Proposed resolution for cancellation of AIM listingPR NewswireProposed Cancellation of Admission of Ordinary Shares to Trading on AIM and Notice of General Meeting Notice of General Meeting to be held on 11 November 2022 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR
- 4y agoABCMABCAM PLC: Interim results for the six-month period ended 30 June 2022PR Newswire20% constant exchange rate revenue growth in H1: Demand for Abcam In-house Products Increases CAMBRIDGE, England and WALTHAM, Mass., Sept. 12, 2022 /PRNewswire/ -- Abcam plc (NASDAQ:ABCM) (AIM: ABC) ('Abcam', the 'Group' or the 'Company'), a global lea